Viewing Study NCT01094405


Ignite Creation Date: 2025-12-25 @ 3:18 AM
Ignite Modification Date: 2026-02-02 @ 6:04 AM
Study NCT ID: NCT01094405
Status: COMPLETED
Last Update Posted: 2021-07-28
First Post: 2010-03-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy
Sponsor: Chinese University of Hong Kong
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epstein-Barr Virus Infections View
None Nasopharyngeal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NPC with persistent, recurrent or metastatic disease patients View